Physician
Anwar Molani MD INC Apmc
Anwar Molani MD INC Apmc was paid $460K by Medicaid between Jan 2018 and Dec 2024, across 84 billing codes. Its largest line is 80048, Basic metabolic panel (calcium, ionized) — 13% of everything it billed.
33Billing provider infoANWAR MOLANI MD INC APMC
ENCINO, CA 91436
ENCINO, CA 91436
33aNPI1770894412assigned 06/28/2010
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$460K
24GClaims310,539
24DCodes billed84
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in California
Rank by total paid#59 of 222
Median peer was paid$42K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,230 | $7K | |
| 2019 | 13,227 | $16K | |
| 2020 | 55,178 | $102K | |
| 2021 | 54,359 | $131K | |
| 2022 | 56,636 | $82K | |
| 2023 | 69,712 | $72K | |
| 2024incomplete | 55,197 | $50K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80048 | Basic metabolic panel (calcium, ionized) | 13% | 34,500 | 19,850 | $59K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 12% | 48,308 | 25,545 | $55K |
| 80053 | Comprehensive metabolic panel | 9.3% | 26,389 | 14,301 | $43K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 6.9% | 2,439 | 1,768 | $32K |
| 83735 | 6.0% | 20,051 | 7,609 | $27K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.9% | 1,076 | 1,008 | $27K |
| 84100 | 3.8% | 18,251 | 6,046 | $18K | |
| 84484 | 3.6% | 13,219 | 10,995 | $17K | |
| 82962 | 3.3% | 9,769 | 2,622 | $15K | |
| 80076 | 3.1% | 15,400 | 13,714 | $14K | |
| 86769 | 2.3% | 328 | 310 | $11K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2.3% | 4,616 | 4,133 | $10K |
72 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.1% | 2,302 | $10K |
| 85730 | 2.0% | 9,260 | $9K | |
| 80061 | Lipid panel | 1.9% | 3,693 | $9K |
| 83690 | 1.8% | 9,401 | $8K | |
| 80202 | 1.7% | 3,128 | $8K | |
| 87040 | 1.4% | 4,378 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.3% | 5,934 | $6K |
| 81001 | 1.1% | 12,872 | $5K | |
| 82550 | 1.0% | 5,496 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,567 | $5K |
| 80299 | <1% | 2,184 | $4K | |
| 82140 | <1% | 1,584 | $4K | |
| 84703 | <1% | 6,540 | $4K | |
| 83605 | <1% | 3,187 | $4K | |
| 85610 | <1% | 6,396 | $4K | |
| 83520 | <1% | 2,363 | $3K | |
| 81000 | <1% | 5,309 | $3K | |
| 87081 | <1% | 1,711 | $3K | |
| 88304 | <1% | 303 | $2K | |
| 87186 | <1% | 1,837 | $2K | |
| 88342 | <1% | 167 | $2K | |
| 85379 | <1% | 1,524 | $2K | |
| 83880 | <1% | 550 | $2K | |
| 87070 | <1% | 1,875 | $2K | |
| 88313 | <1% | 171 | $2K | |
| 82977 | <1% | 2,738 | $1K | |
| 83615 | <1% | 1,414 | $1K | |
| 84702 | <1% | 1,205 | $1K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 37 | $1K |
| 86140 | <1% | 481 | $1K | |
| 80305 | <1% | 385 | $1K | |
| 84436 | <1% | 1,238 | $921.23 | |
| 82728 | <1% | 624 | $774.87 | |
| 84165 | <1% | 465 | $723.47 | |
| 85007 | <1% | 2,037 | $714.38 | |
| 83540 | <1% | 613 | $682.82 | |
| 87077 | <1% | 371 | $614.38 | |
| 86328 | <1% | 380 | $578.24 | |
| 83550 | <1% | 583 | $530.52 | |
| 86850 | <1% | 921 | $527.93 | |
| 87400 | <1% | 584 | $439.36 | |
| 82607 | <1% | 323 | $410.29 | |
| 85378 | <1% | 227 | $356.97 | |
| 87536 | <1% | 36 | $337.73 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 32 | $298.87 |
| 88312 | <1% | 24 | $282.64 | |
| 84439 | <1% | 262 | $276.42 | |
| 82746 | <1% | 157 | $252.16 | |
| 80320 | <1% | 2,511 | $241.37 | |
| 82553 | <1% | 200 | $234.59 | |
| 86592 | <1% | 471 | $222.89 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 128 | $196.53 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 204 | $178.72 |
| 86480 | <1% | 13 | $137.47 | |
| 84300 | <1% | 109 | $121.01 | |
| 88311 | <1% | 129 | $120.04 | |
| 86803 | <1% | 84 | $115.77 | |
| 82150 | <1% | 138 | $107.08 | |
| 81003 | <1% | 580 | $103.13 | |
| 80074 | <1% | 26 | $101.42 | |
| 82570 | <1% | 44 | $56.24 | |
| 87350 | <1% | 15 | $47.93 | |
| 80329 | <1% | 225 | $45.15 | |
| 85651 | <1% | 113 | $34.00 | |
| 86900 | <1% | 89 | $29.74 | |
| 87520 | <1% | 13 | $25.62 | |
| 82947 | <1% | 88 | $20.45 | |
| 87420 | <1% | 54 | $19.30 | |
| 87340 | <1% | 15 | $16.28 | |
| 84550 | <1% | 34 | $15.05 | |
| 85652 | <1% | 25 | $7.86 | |
| 82270 | <1% | 16 | $5.58 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOLANI, MUHAMMAD (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Molani Medical Group a Professional Medical Corp. | Sherman Oaks, CA | $81K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.